Raises Concerns Surrounding Lucien Selce s Self-Serving Proposals and Lack of Credibility
Glass Lewis Recommends that Aurinia Shareholders Vote FOR the Re-Election to the Board of Directors of All.
Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.
StockWatch: Biogen's Q4 Results Disappoint Analysts genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
PRINCETON, N.J. & TOKYO & WALTHAM, Mass. (BUSINESS WIRE) Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC); Otsuka Pharmaceutical, Co. Ltd. (Otsuka); and Visterra, Inc., an Otsuka group company announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designat.